
An analysis of Gilead Sciences (GILD) options highlights strategies for yield enhancement or discounted share acquisition, with the stock trading at $114.91. A cash-secured put at the $105 strike (bid $1.34) offers a potential 10.83% annualized yield if it expires worthless, while a covered call at the $116 strike (bid $2.26) provides a 16.69% annualized yield if not called away, or a 2.92% return if assigned. These 'YieldBoost' strategies present alternative entry points or income generation for investors interested in GILD, noting implied volatilities of 40% for the put and 30% for the call against GILD's 26% trailing historical volatility.
Analysis of Gilead Sciences (GILD), trading at $114.91, reveals two distinct options strategies for investors. The first is a cash-secured put at the $105.00 strike, which presents an opportunity to acquire shares at an effective cost basis of $103.66—a 9% discount to the current price—or to generate a 10.83% annualized yield if the put expires worthless, an event with a 78% probability according to current models. The second strategy is a covered call at the $116.00 strike, designed for current shareholders to generate income. This offers a potential 16.69% annualized yield if the option expires out-of-the-money, an outcome with a 51% probability, or a 2.92% total return if the shares are called away. A key observation is the variance in volatility metrics: the put's implied volatility is 40% and the call's is 30%, both significantly higher than GILD's trailing twelve-month historical volatility of 26%. This discrepancy suggests that options premiums are currently elevated, potentially making option-selling strategies more attractive than historical pricing would imply.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment